Immunocore
IMCR
IMCR
149 hedge funds and large institutions have $2.68B invested in Immunocore in 2024 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 64 increasing their positions, 39 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
2.85% more ownership
Funds ownership: 79.92% → 82.77% (+2.9%)
2% more capital invested
Capital invested by funds: $2.63B → $2.68B (+$54.1M)
13% less funds holding in top 10
Funds holding in top 10: 8 → 7 (-1)
Holders
149
Holding in Top 10
7
Calls
$49.2M
Puts
$8.29M
Top Buyers
| 1 | +$170M | |
| 2 | +$93.3M | |
| 3 | +$36.2M | |
| 4 |
LGM
Logos Global Management
San Francisco,
California
|
+$32.5M |
| 5 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
+$23.3M |
Top Sellers
| 1 | -$67.1M | |
| 2 | -$65.4M | |
| 3 | -$41.8M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$33M |
| 5 |
CAC
Cowen and Company
New York
|
-$27M |